Ponoi Capital II, LP, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 184,272 shares at $5.00 ($921K) on 2023-01-30, disclosed to the SEC on 2023-02-01.
Open-market purchase of $921k NGM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 7,542 | $38K | 4.1% |
| 2 | $5.00 | 176,730 | $884K | 95.9% |
| Total | $5.00 avg | 184,272 | $921K | 100% |
| Filing → |
| NGM | BUY | 2022-05-17 | $842K | — | Filing → |
| RAPT | SELL | 2021-09-29 | $578K | — | Filing → |
| NGM | BUY | 2020-03-25 | $7.1M | — | Filing → |